Press Releases - Page 2 of 5 - F-Star Therapeutics Inc.

Nov 10, 2021

F-star Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update »

Nov 1, 2021

F-star Therapeutics to Announce Third Quarter Results and Host Conference Call on November 10, 2021 »

Oct 20, 2021

F-star Therapeutics Announces License Agreement with Janssen to Develop and Commercialize Multiple Next Generation Bispecific Antibody Therapeutics »

Sep 16, 2021

F-star Therapeutics to Present FS120 Phase 1 Trial-in-Progress Update at ESMO 2021 »

Sep 9, 2021

F-star Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference »

Aug 12, 2021

F-star Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update »

Aug 10, 2021

F-star Therapeutics is Granted Composition of Matter Patent for its Novel Second Generation STING Agonist, SB 11285 »

Aug 4, 2021

F-star Therapeutics Announces Collaboration with MSD to Evaluate FS120 in Combination with KEYTRUDA »

Aug 2, 2021

F-star Therapeutics to Announce Second Quarter Results and Host Conference Call on August 12, 2021 »

Jul 26, 2021

F-star Therapeutics Provides Interim Update on SB 11285 First-In-Human Dose-Escalation Study in Patients with Advanced Solid Tumors »

Jul 9, 2021

F-star Therapeutics to Present at Upcoming Investor Conferences »

Jul 8, 2021

F-star Therapeutics Enters into Exclusive Licensing Agreement with AstraZeneca for Novel STING Inhibitors »

May 17, 2021

F-star Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update »

May 10, 2021

F-star Therapeutics to Announce First Quarter Results and Corporate Update Call on May 17, 2021 »

May 7, 2021

F-star Therapeutics, Inc. Announces Pricing of $65 Million Public Offering of Common Stock »

May 6, 2021

F-star Therapeutics, Inc. Announces Proposed Public Offering of Common Stock »

Apr 29, 2021

Cancer Trial Highlights Potential for Checkpoint Inhibitors »

Apr 19, 2021

Study Published in Nature Shows F-Star’s STING Agonist SB 11285 Enhances Preclinical Efficacy of Radiation Therapy »

Apr 10, 2021

F-star Therapeutics Shows Differentiation of FS222 in 2021 AACR Poster »

Apr 1, 2021

F-star Therapeutics Announces Third Option Exercised by Merck KGaA, Darmstadt, Germany in Immuno-Oncology Collaboration »

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Others